| Actionable tumor alterations and treatment protocol enrollment of pediatric and young adult patients with refractory cancers in the National Cancer Institute–Children's … DW Parsons, KA Janeway, DR Patton, CL Winter, B Coffey, PM Williams, ... Journal of Clinical Oncology 40 (20), 2224-2234, 2022 | 71 | 2022 |
| Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: a retrospective review of 100 cases P Nagarajan, JL Curry, J Ning, J Piao, CA Torres-Cabala, PP Aung, ... Clinical Cancer Research 23 (8), 2093-2104, 2017 | 61 | 2017 |
| Study of unilateral retinoblastoma with and without histopathologic high-risk features and the role of adjuvant chemotherapy: a Children’s Oncology Group Study P Chévez-Barrios, RC Eagle Jr, M Krailo, J Piao, DM Albert, Y Gao, ... Journal of Clinical Oncology 37 (31), 2883-2891, 2019 | 58 | 2019 |
| B7-H4 expression in ovarian serous carcinoma: a study of 306 cases L Liang, Y Jiang, JS Chen, N Niu, J Piao, J Ning, Y Zu, J Zhang, J Liu Human pathology 57, 1-6, 2016 | 44 | 2016 |
| The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database B Haeberle, A Rangaswami, M Krailo, P Czauderna, E Hiyama, ... Pediatric blood & cancer 67 (8), e28350, 2020 | 41 | 2020 |
| Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R CB Benton, M Khan, D Sallman, A Nazha, GM Nogueras González, J Piao, ... American journal of hematology 93 (10), 1245-1253, 2018 | 36 | 2018 |
| Identification of targetable molecular alterations in the NCI-COG Pediatric MATCH trial. DW Parsons, KA Janeway, D Patton, B Coffey, PM Williams, SR Hamilton, ... Journal of Clinical Oncology 37 (15_suppl), 10011-10011, 2019 | 33 | 2019 |
| Phase II study of selumetinib in children and young adults with tumors harboring activating mitogen-activated protein kinase pathway genetic alterations: arm E of the NCI-COG … OS Eckstein, CE Allen, PM Williams, S Roy-Chowdhuri, DR Patton, ... Journal of Clinical Oncology 40 (20), 2235-2245, 2022 | 29 | 2022 |
| Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children’s oncology group AHEP 0731 liver tumor committee CB Weldon, AL Madenci, GM Tiao, SP Dunn, MR Langham, ... Journal of pediatric surgery 55 (4), 655-659, 2020 | 28 | 2020 |
| Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features P Nagarajan, J Piao, J Ning, LE Noordenbos, JL Curry, CA Torres-Cabala, ... Modern Pathology 33 (3), 496-513, 2020 | 28 | 2020 |
| A multi-institutional pooled analysis demonstrates that circulating miR-371a-3p alone is sufficient for testicular malignant germ cell tumor diagnosis J Piao, JT Lafin, CG Scarpini, MM Nuño, I Syring, KP Dieckmann, G Belge, ... Clinical genitourinary cancer 19 (6), 469-479, 2021 | 23 | 2021 |
| Maximum likelihood estimation and EM algorithm of Copas-like selection model for publication bias correction J Ning, Y Chen, J Piao Biostatistics 18 (3), 495-504, 2017 | 23 | 2017 |
| Intensive multimodality therapy for extraocular retinoblastoma: a children's oncology group trial (ARET0321) IJ Dunkel, J Piao, GL Chantada, A Banerjee, S Abouelnaga, ... Journal of Clinical Oncology 40 (33), 3839-3847, 2022 | 20 | 2022 |
| Doxorubicin in combination with cisplatin, 5‐flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study HM Katzenstein, MH Malogolowkin, MD Krailo, J Piao, AJ Towbin, ... Cancer 128 (5), 1057-1065, 2022 | 20 | 2022 |
| Trial design challenges and approaches for precision oncology in rare tumors: experiences of the Children’s Oncology Group LA Renfro, L Ji, J Piao, A Onar-Thomas, JA Kairalla, TA Alonzo JCO Precision Oncology 1, 1-13, 2019 | 20 | 2019 |
| Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C SN Chi, JS Yi, PM Williams, S Roy-Chowdhuri, DR Patton, BD Coffey, ... JNCI: Journal of the National Cancer Institute 115 (11), 1355-1363, 2023 | 17 | 2023 |
| Small cell undifferentiated histology does not adversely affect outcome in hepatoblastoma: a report from the Children's Oncology Group (COG) AHEP0731 Study Committee A Trobaugh-Lotrario, HM Katzenstein, S Ranganathan, D Lopez-Terrada, ... Journal of Clinical Oncology 40 (5), 459-467, 2022 | 13 | 2022 |
| Copas-like selection model to correct publication bias in systematic review of diagnostic test studies J Piao, Y Liu, Y Chen, J Ning Statistical methods in medical research 28 (10-11), 2912-2923, 2019 | 9 | 2019 |
| Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731 SA Vasudevan, RL Meyers, MJ Finegold, D López-Terrada, ... Journal of pediatric surgery 57 (10), 251-256, 2022 | 8 | 2022 |
| Imaging appearance of nongerminoma pediatric ovarian germ cell tumors does not discriminate benign from malignant histology D Billmire, B Dicken, F Rescorla, J Ross, J Piao, L Huang, M Krailo, ... Journal of pediatric and adolescent gynecology 34 (3), 383-386, 2021 | 8 | 2021 |
Jing NingThe University of Texas MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
